LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Buys/Adds (2)
Qube Research
$59.1M
bought
Citadel
$31.1M
added
Sells/Trims (1)
Two Sigma
$27.9M
sold
Top-trader positions in UHS could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 27, 2026
Period ending
Jun 30, 2026
Earnings per share
$6.01 expected
Estimates as of Oct 24, 2026
EPS expected
$4.35 to $5.65
Revenue expected
15 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | $5.98 / $6.01Yahoo Finance | -0.45% in line | $4.64B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 27, 2026 | $5.62 / $5.46Yahoo Finance | +2.95% beat | $4.50B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 25, 2026 | $5.88 / $5.91Yahoo Finance | -0.51% in line | $4.49B No estimate | Unavailable |
| Sep 30, 2025 | Oct 27, 2025 | $5.69 / $4.95Yahoo Finance | +14.91% beat | $4.50B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 28, 2025 | $5.35 / $4.96Alpha Vantage | +7.86% beat | $4.28B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 28, 2025 | $4.84 / $4.36Alpha Vantage | +11.01% beat | $4.10B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 26, 2025 | $4.92 / $4.18Alpha Vantage | +17.84% beat | $4.11B No estimate | Unavailable |
| Sep 30, 2024 | Oct 24, 2024 | $3.71 / $3.70Alpha Vantage | +0.27% in line | $3.96B No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $4.50B | $4.49B | $4.50B | $4.64B |
| Cost of what it sold | $414.6M | $422.8M | $426.5M | $423.3M |
| Gross profit | $4.08B | $4.06B | $4.07B | $4.21B |
| What it spent | ||||
| Sales and admin | $2.11B | $2.09B | $2.13B | $2.14B |
| Other operating costs | $1.45B | $1.46B | $1.44B | $1.56B |
| Total operating expenses | $3.56B | $3.55B | $3.57B | $3.70B |
| What was left | ||||
| Operating profit | $521.7M | $517.2M | $502.9M | $516.7M |
| Interest on debt | $37.4M | $42.5M | $36.0M | $39.9M |
| Profit before tax | $496.9M | $581.4M | $469.1M | $479.1M |
| Tax | $117.8M | $133.6M | $110.4M | $114.5M |
| Net profit | $373.0M | $445.9M | $348.7M | $358.4M |
| EBITDA | $689.3M | $786.0M | $660.5M | $684.0M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Universal Health Services Inc. Cl B stock underperforms Wednesday when compared to competitors
BearishOct 21Molina Healthcare, Inc. (MOH) Stock Price, News, Quote & History
NeutralOct 21Raymond James sets USD 39.00 target for Acadia Healthcare stock
NeutralOct 20HCA Healthcare stock: USD 0.78 dividend gives HCA Healthcare stock a 0.70 percent yield
NeutralOct 20Concentra opening health clinic near Reagan National Airport, plots further N. Va. expansion
Leans bullishOct 20Molina Healthcare, Inc. (MOH) stock price, news, quote and history
Leans bullishOct 20Pediatrix Medical Group, Inc. (MD) Stock forecasts
Leans bullishOct 20Universal Health Services Inc. Cl B stock outperforms competitors despite losses on the day
NeutralOct 1921 macro signals shaping UHS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
